Israel’s Adjuvant industry | Opportunities | Upcoming Projects|Investment opportunities |Forecast to 2020
Market Entry - Adjuvant Industry in Israel: Analysis of Growth, Trends and Progress (2016 - 2021)

PUBLISHED

DEC 2017

Market Entry - Adjuvant Industry in Israel: Analysis of Growth, Trends and Progress (2016 - 2021)

Purchase Report

About the Market

Increase in the prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer, with growth in preference for the future prevention of cancer are some of the major drivers of this market. The overall market for oncology adjuvants is classified on the basis of applications such as chemotherapy, radiotherapy, immunotherapy etc. By diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. North America, followed by Europe dominates the global market for breast cancer treatment, due to increasing incidence of cancer cases and technological advancement in the region. Some of the market players in this industry include pharmaceutical manufacturers such as Amgen Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, and Pfizer Inc.

About the Geography

Israel is a small country located in the Middle East bordered by Egypt, Jordan, Lebanon, and Syria. Israel has a liberal investment system and most activities are open to both private nationals and foreign investors. It has many tech start-ups, funded by America, a strong R7D sector, and a highly skilled multi-lingual workforce.

The government encourages entrepreneurship and the country is the second largest regarding the availability of venture capital. The recent revision of Encouragement of Capital Investments Law now includes financial incentives for foreign investments. Israel is bordered by countries with on-going wars and terrorist activities, which act as a major impediment for foreign investors. It also has high corporate taxes and cost of manpower.

Israel invests almost 5% of its GDP in R&D and has many highly qualified engineers with access to funds. For these reasons, Israel is a good country to invest in if a company wants to set up an R&D wing, branch office, or LLC.

 

Component Name

Unit

GDP (USD billion)

296

GDP Annual Growth Rate

3.2

GDP Per Capita

32828

Unemployment Rate

4.6

Wages

2563.21

Inflation Rate

-0.7

Consumer Price Index (CPI)

99.2

Interest Rate

0.1

Loans to Private Sector (USD billion)

150.026

Balance of Trade (USD billion)

-1.899

Business Confidence

19.2

Manufacturing PMI (Index Points)

57 Index Points

Ease of Doing Business

53

Competitiveness Rank

24

Corruption Rank

32

Consumer Confidence

-14.51

Consumer Spending (USD billion)

41.537

Bank Lending Rate (Consumers)

3.4

Corporate Tax Rate

26.5

Sales Tax Rate

18

 

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

                1.1 Scope of the Report

                1.2 Regional Analysis

                                1.2.1 PESTLE Analysis

                                1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

                2.1 Drivers

                2.2 Restraints

                2.3 Opportunities

3. Market Demand Analysis

                3.1 Socio-Economic Segmentation

                3.2 Demographic Strengths & Weaknesses

                3.3 Spending Patterns

                3.4 Target Market Identification

4. Market Size of Adjuvant Industry (USD millions)

                4.1 By Types of Inorganic Compounds

                4.2 By Bacterial Products

5. Market Entry

                5.1 Market Entry: The Strategy

                                5.1.1 Types of Entry Modes, by Market Entry Objectives

                                5.1.2 Competition Analysis

                                                5.1.2.1 Market Share

                                                5.1.2.2 Strategies Adopted, Recent Events 

                                5.1.3 Pricing Strategy

                                5.1.4 Supply Chain Analysis

                                                5.1.4.1 Trade (Import-Export Analysis)

                                                5.1.4.2 Distribution Network & Retail Analysis

                5.2 Market Entry: The Administration

                                5.2.1 How to Register a Company (Flowchart)

                                5.2.2 Registration Processes 

                                                5.2.2.1 Ministries Involved

                                                5.2.2.2 Criteria and Conditions

                                5.2.3 List of Forms & Documents

                                5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Purchase Report

Our Clients Include View All

Looking to Customize Report?